期刊文献+

布舍瑞林的合成 被引量:7

Synthesis of buserelin
原文传递
导出
摘要 目的:探索布舍瑞林的合成方法。方法:先采用Fmoc固相多肽合成法,以2-CTC(2-chlorotrityl chloride)树脂做载体,DIC/HOBT做缩合剂,逐步缩合得到全保护布舍瑞林肽树脂,以2%TFA/DCM切割树脂,然后在PyBOP催化下接乙胺基,再用钯碳和甲酸铵催化氢化脱除硝基和苄基,最后用15%TFA/DCM选择性脱去三苯甲基保护基得粗肽,半制备反相高效液相色谱法纯化。结果:布舍瑞林粗品纯度达80%,粗品经半制备反相高效液相色谱纯化,所得精肽纯度大于98%,总收率为30%。结论:该方法工艺简单,产品成本低,纯度高,可为工业化生产提供借鉴。 Objective: To develop a method for synthesis of buserelin. Methods: Buserelin was synthesized by Fmoc solid phase peptide synthesis method using 2-CTC (2-chlorotrityl chloride) resin as a solid carrier and DIC/HOBT as condensing agents. The protected peptide was obtained by cleavage with 2% TFA/DCM and coupled with ethylamine by using PyBOP as a coulpling reagent, and the crude peptide was obtained following the hydrogenation and selective deprotection of Trt. The pure buserelin was obtained after purification on semi-preparative RP-HPLC. Results: The purity of the crude peptide was more than 80%. After the purification by semi-preparative RP-HPLC, the purity was more than 98% , and the overall yield was 30%. Conclusion: The method is simple and cost-effective, and can produce buserelin with high purity, which may be useful for the industrial production.
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第15期1806-1810,共5页 Chinese Journal of New Drugs
关键词 布舍瑞林 多肽合成 催化氢化 脱保护 buserelin peptide synthesis hydrogenation deprotection
  • 相关文献

参考文献8

  • 1田玲,路学智.瑞林类人工合成肽类药物的研究进展[J].中国新药杂志,2006,15(20):1723-1726. 被引量:15
  • 2武国海,周彩红,王明伟.前列腺癌治疗药物的研究新进展[J].中国新药杂志,2007,16(17):1330-1336. 被引量:4
  • 3徐峰,路杨,杨东晖,等.一种布舍瑞林的合成方法:中国,10039548.9[P].2010-6-16.
  • 4KIM KM, RYOO SJ, CHA KH, et al. A method for preparing peptides using by solid phase synthesis: WO, 044890 A1 [ P]. 2008 - 4 - 16.
  • 5BERTA PO, MARC CP, GEMMA JF, et al. Peptide synthesis procedure in solid phase: US, 6897289 B1 [ P]. 2005 -5 -24.
  • 6林浩,王德心.哌嗪二酮衍生物的合成研究进展[J].药学学报,2003,38(5):395-400. 被引量:11
  • 7ALBERICIO F. Developments in peptide and amide synthesis [J]. Curr Opin Chem, 2004, 8(3): 211 -221.
  • 8ESPOSITO E, KAPTEIN B, BROXTERMAN Q, et al. Amino acid bromides: their utilization for difficult couplings in solid- phase peptide synthesis [ J ]. Tetrahedron Lett, 2005, 46 ( 3 ) : 6369 - 6371.

二级参考文献68

  • 1谭红.曲普瑞林在子宫内膜异位症术后的临床应用[J].药物流行病学杂志,2004,13(4):180-182. 被引量:5
  • 2[1]Goodman M, Stueben KC. Peptide synthesis via amino acid active esters. II. Some abnormal reaction during peptide synthesis [J]. J Am Chem Soc, 1962,84(7):1279-1283.
  • 3[2]Gisin BF, Merrifield RB. Carboxyl-catalyzed intramolecular aminolysis. Side reaction in solid-phase peptide synthesis [J]. J Am Chem Soc, 1972,94(9):3102-3106.
  • 4[3]Khosla MC, Smeby RR, Bumpus F. Failure sequence in solid-phase peptide synthesis due to the presence of an N-alkylamino acid [J]. J Am Chem Soc, 1972,94(13):4721-4724.
  • 5[4]Giralt E, Eritja R, Pedroso E. Diketopiperazine formation in acetamido- and nitrobenzamido-bridged polymer supports [J]. Tetrahedron Lett, 1981,22(38):3779-3782.
  • 6[5]Cui CB, Kakeya H, Osada H. Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase [J]. Tetrahedron, 1996,52(39):12651-12666.
  • 7[6]Cui CB, Kakeya H, Okada Gen, et al. Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. I. Taxonomy, fermentation, isolation and biological properties [J]. J Antibiot, 1996,49(6):527-533.
  • 8[7]Edmondson S, Danishefsky SJ, Sepp-Lorenzino L, et al. Total synthesis of spirotryprostatin A, leading to the discovery of some biologically promising analogues [J]. J Am Chem Soc, 1999,121(10):2147-2155.
  • 9[8]Sanatamaria A, Cabezas N, Avendano C. Synthesis of tryptophan-dehydrobutyrine diketopeperazines and analogues [J]. Tetrahedron, 1999,55(4):1173-1186.
  • 10[9]Chu Min, Ronald M, Imbi T, et al. Two novel diketopiperazines isolated from the fungus tolypocladium SP. [J]. Tetrahedron Lett, 1993,34(47):7537-7540.

共引文献29

同被引文献50

  • 1潘芹芹,崔毓桂,王兴海.促性腺激素释放激素及其类似物的研究进展[J].生殖医学杂志,2004,13(4):244-247. 被引量:5
  • 2张鸿鹏,甘一如.多肽液相分段合成及其进展[J].化学工业与工程,2006,23(3):254-259. 被引量:8
  • 3田玲,路学智.瑞林类人工合成肽类药物的研究进展[J].中国新药杂志,2006,15(20):1723-1726. 被引量:15
  • 4吴永平.缩宫素的制备方法:中国,200810084940.8[P].2008-08-06.
  • 5周逸明.固相多肽合成缩宫素的制备方法:中国,200510112356.5[P].2007-07-04.
  • 6徐峰,路杨,杨东晖,等.一种布舍瑞林的合成方法:中国,10039548.9[P].2010-6-16.
  • 7王宇,杨祺.促黄体生成素释放激素衍生物的合成方法:中国,102190709A[P].2011-09-21.(CA,2011,153:502411).
  • 8李红玲,袁建成,陈大来,等.一种固相制备布舍瑞林的方法:中国,101935339A[P].2013-07-03.(CA,2011,154:182860).
  • 9Lee HJ, Macbeth AH, Pagani JH, et al. Oxytocin: the great facilitator of life [J]. Prog Neurobio, 2009, 88 (10) : 127-151.
  • 10Bodanszky M, Vigneaud VD. A method of synthesis of long peptide chains using a synthesis ofoxytocin as an example [J]. JAm Chem Soc, 1959, 81 (21) : 5688-5691.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部